Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Pfizer will copromote Searle's COX-2 inhibitors in U.S.

Feb. 20, 1998

FDA approves new indication for pilocarpine

Feb. 19, 1998

Small-molecule chemokine receptor antagonists from Teijin

Feb. 18, 1998

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

New NSAID from Maruho and Toyama (M-5011) compares favorably with known compounds

Feb. 16, 1998

Pharmacokinetic/pharmacodynamic characterization of CP-105696 in volunteers

Feb. 13, 1998

Biphenylsulfonamides with MMP-inhibitory effects developed at Warner-Lambert

Feb. 13, 1998

Inhibitors of secretory PLA2 produced by Streptomyces violaceusniger

Feb. 12, 1998

New antiinflammatory agents prepared by Brazilian academics

Feb. 11, 1998

Idec evaluates humanized anti-gp39 antibody in phase I

Feb. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026